2012 Program Booklet - MCD Biology - University of Colorado Boulder
2012 Program Booklet - MCD Biology - University of Colorado Boulder
2012 Program Booklet - MCD Biology - University of Colorado Boulder
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Keynote Speaker:<br />
William Freytag, PhD<br />
Former Chairman and CEO, Myogen,<br />
<strong>Boulder</strong>, CO<br />
Title: Fifteen Years and $1.3 Billion Later<br />
Friday, October 12<br />
5:10 – 6:10 pm<br />
JSCBB Butcher Auditorium<br />
Abstract:<br />
It is the mission <strong>of</strong> pharmaceutical research companies to take the path from understanding a<br />
disease to bringing a safe and effective new treatment to patients. Scientists work to piece<br />
together the basic causes <strong>of</strong> disease at the level <strong>of</strong> genes, proteins and cells. Out <strong>of</strong> this<br />
understanding emerge “targets”, which potential new drugs might be able to<br />
affect. Researchers work to: (i) validate these targets, (ii) discover molecules (potential drug)<br />
that interact with the chosen target, (iii) test these new compounds in the lab and clinic for<br />
safety and efficacy, and (iv) gain regulatory approval and get the drug into the hands <strong>of</strong><br />
doctors and patients. This whole process typically takes 10-‐15 years and an expenditure <strong>of</strong><br />
$1.3 billion.
Change language